Skip to content


  • Meeting abstracts
  • Open Access

Human herpesvirus type 8 variants in Kaposi's sarcoma before and after AIDS era

  • 1,
  • 2,
  • 2,
  • 3,
  • 4,
  • 4,
  • 5,
  • 1,
  • 2,
  • 1 and
  • 1Email author
Infectious Agents and Cancer20105 (Suppl 1) :A37

  • Published:


  • Human Herpesvirus
  • Diverse Geographic Region
  • Direct Nucleotide Sequencing
  • Human Herpesvirus Type
  • Large Predominance


Human herpesvirus 8 (HHV- 8) variants have been found heterogeneously distributed among human populations living in diverse geographic regions, but their differential pathogenicity in Kaposi's sarcoma (KS) development remains controversial. The aim of the present study was to analyze variations of HHV-8 genomes in tumor biopsies collected before and in the course of HIV epidemic (1971 - 2008), from patients with classic, iatrogenic, endemic as well as epidemic KS living in Africa, Europe, and North America.

Materials and methods

DNA samples have been extracted from cutaneous KS lesions of 68 patients living in Africa (n=23, Cameroon, Kenya and Uganda), Europe (n=34, Greece and Italy), and North America (n=11). The identification and characterization of HHV-8 variants has been based on PCR amplification followed by direct nucleotide sequencing and phylogenetic analysis of the highly conserved ORF 26 and T0.7, the hypervariable ORF K1, as well as on the analysis of P and M alleles of the K14.1/15 locus.


Among the 23 African samples, the majority of HHV-8 ORF 26 variants clustered with the subtype R (n=12) and B (n=5). Conversely, the viral sequences obtained from 45 European and North European tumors belonged mainly to subtype A/C (n=36). In general HHV-8 and K1 variant clustering paralleled that of ORF 26 and T0.7. Genotyping of the K14.1/15 loci revealed a large predominance of P subtype in all tumors.


Although the virus has genetic regions of high variability, approaching that of HIV-1 env gene, the HHV-8 subtypes remained stably distributed before and after the AIDS epidemic. These results suggest that the increased incidence of epidemic KS in low-incidence countries was not related to the spreading of high pathogenic HHV-8 variants, furthermore, suggest the presence of other cofactors in high risk KS countries pre-existing in pre-AIDS era [1].



We thank the late Prof SK Kyalwazi (Mulago Hospital, Kampala, Uganda), Prof VA Ngu (Univ., Yaounde, Cameroon), Prof B Safai (Sloan-Kettering/Memorial Hospital New York City, USA), Prof. N Mueller (Harvard School of Public Health, Boston, USA) and Prof G Giraldo (Natl Cancer Inst. Fond. Pascale, Napoli, Italy), for patients enrollement.

This article has been published as part of Infectious Agents and Cancer Volume 5 Supplement 1, 2010: Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI).The full contents of the supplement are available online at

Authors’ Affiliations

Molecular Biology and Viral Oncology & AIDS Reference Centre, National Cancer Institute "Fondazione Pascale", Naples, Italy
Uganda Virus Research Institute, P.O. Box 49 Entebbe, Uganda
University of Athens, Athens, Greece
Institute of Dermatological Sciences, University and IRCCS Ospedale Maggiore, Milan, Italy
Department of Dermatology, Second University of Naples, Naples, Italy


  1. Tornesello ML, Biryahwaho B, Downing R, Hatzakis A, Alessi E, Cusini M: Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology. 2010, 398: 280-289. 10.1016/j.virol.2009.12.005.View ArticlePubMedGoogle Scholar


© Buonaguro et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.